The Psychedelic Medicine Association brings together medical professionals to educate and guide each other over emerging science, ethics, and cultural issues in the rapidly developing field of psychedelic medicine.
In this week’s Trip Report, Field Trip Psychedelics becomes the third publicly traded psychedelic company, MindMed & NYU team up to train psychedelic providers and researchers, The New Yorker covers the first NYC psychedelic clinic, and more.
This week’s Trip Report features announcements on Numinus and Field Trip that paint a story of two different approaches and two different challenges, plus AWAKN expands its scientific board, and more.
In this week’s Trip Report, Berkeley’s new psychedelic research center will focus on spiritual and theological investigations alongside scientific research, and COMPASS files to be listed on the NASDAQ.
In this week’s Trip Report, England’s National Institute for Health and Care Excellence rejects Spravato, some of the most prominent names in psychedelics will gather for Psych Congress 2020, and more.
David Bronner talks about his company’s 10 year financial commitment to the Multidisciplinary Association for Psychedelic Studies, the importance of supporting MAPS’ nonprofit approach to MDMA research, Dr. Bronner’s “Heal Soul” campaign, and more.
A Salt Lake City doctor claims his method of using high dose intramuscular injections of ketamine is novel, but other ketamine clinicians say it’s not a new discovery.
**Contribute to the Future of Psychedelics** Make an investment in a healthy psychedelic future by supporting this community-funded initiative. For the last 3 years, Lucid News has been providing indispensable journalism covering the psychedelic field. We are now turning to our readers to continue building. We understand that not everyone is in a position to pay for this vital information, but if you are, we need you. *Make an investment in quality journalism, so others can benefit. You can give just once or monthly. Thank you.*
**Contribute to the Future of Psychedelics** Make an investment in a healthy psychedelic future by supporting this community-funded initiative. For the last 3 years, Lucid News has been providing indispensable journalism covering the psychedelic field. We are now turning to our readers to continue building. We understand that not everyone is in a position to pay for this vital information, but if you are, we need you. *Make an investment in quality journalism, so others can benefit. You can give just once or monthly. Thank you.*